Acadia Pharma (ACAD) – Downgrades
-
Acadia Pharma (ACAD) to stop pimavanserin trials after failure
-
Mizuho Downgrades Acadia Pharmaceuticals (ACAD) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ACAD Stock Lookup